Xtest

Tempe, United States Founded: 2015 • Age: 11 yrs
Xtest develops biosensors and apps for accurate diagnosis of sexually transmitted diseases.
Annual revenue - Latest available
Total funding $50,000 2 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About Xtest

Xtest is a company based in Tempe (United States) founded in 2015. It operates as a B2B. Xtest has raised $50 thousand across 2 funding rounds. Xtest operates in a competitive market with competitors including CellScope, Nuclein, Mel-Mont Medical, Orphidia and ParaSonic, among others.

  • Headquarter Tempe, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $50 K (USD)

    in 2 rounds

  • Latest Funding Round
    $200 K (USD), Debt – Conventional

    Feb 26, 2018

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Xtest

Xtest has successfully raised a total of $50K across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $200 thousand completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Xtest

Investments
Premium access

Investment portfolio details for Xtest

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Xtest

Premium access

Detailed financials for Xtest

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Xtest Comparisons

Xtest Primary company
Description
Xtest develops biosensors and apps for accurate diagnosis of...
Location
Tempe, United States
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Xtest

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Xtest

Xtest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CellScope, Nuclein, Mel-Mont Medical, Orphidia and ParaSonic, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
In-ear visibility is enabled by smartphone-attached otoscope for at-home diagnosis.
Locked Locked Locked
Handheld PCR devices for infectious disease detection are developed.
Locked Locked Locked
Molecular screening devices for early infectious disease detection are developed.
Locked Locked Locked
Handheld device for point-of-care chronic disease diagnostics is developed.
Locked Locked Locked
Offers a home-use device for effectively eliminating lice and other parasites.
Premium access

Detailed competitors of Xtest

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Xtest

Premium access

Complete news archive for Xtest

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Xtest

Xtest was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Xtest is headquartered in Tempe, United States. It is registered at Tempe, Arizona, United States.

Xtest is a funded company, having raised a total of $50K across 2 funding rounds to date.

Xtest, established in 2015 and currently in Dissolved stage, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and biosensors. Xtest develops biosensors and apps for accurate diagnosis of sexually transmitted diseases. Adapting to market demands with innovation and client-focused strategies.

Xtest's top competitors include Nuclein, CellScope and Mel-Mont Medical.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available